No black box warning on record for Levobunolol Hydrochloride

As of the latest FDA labeling reviewed, Levobunolol Hydrochloride (LEVOBUNOLOL HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Levobunolol Hydrochloride medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS As with other topically applied ophthalmic drugs, levobunolol hydrochloride ophthalmic solution may be absorbed systemically. The same adverse reactions found with systemic administration of beta-adrenergic blocking agents may occur with topical administration. For example, severe respiratory reactions and cardiac reactions, including death due to bronchospasm in patients with asthma, and

No black box warning on record for Levobunolol Hydrochloride

Other warnings & precautions

WARNINGS As with other topically applied ophthalmic drugs, levobunolol hydrochloride ophthalmic solution may be absorbed systemically. The same adverse reactions found with systemic administration of beta-adrenergic blocking agents may occur with topical administration. For example, severe respiratory reactions and cardiac reactions, including death due to bronchospasm in patients with asthma, and

Levobunolol Hydrochloride Black Box Warning

No black box warning on record for Levobunolol Hydrochloride

Other warnings & precautions

Levobunolol Hydrochloride Black Box Warning

No black box warning on record for Levobunolol Hydrochloride

Other warnings & precautions